In our view PFE is a solid core asset holdign in the pharma industry. Interesting dividend yeld of 3.40% and solid cash flow. Our earning estimate for the 2019 are 2.00 dollars per share.
Net annual profit: 11.1 Bilions
Total debt: 42.0 Bilions
Net annual profit: 11.1 Bilions
Total debt: 42.0 Bilions
